Stawamycin: synthetic studies

Author(s)

Gliseida Zelayaran Melgar

• Document type: Doctoral Thesis
• Press: Campinas, SP.
• Institution: Universidade Estadual de Campinas (UNICAMP). Instituto de Química
• Defense date: 2008-05-09

Examining board members

Luiz Carlos Dias; Timothy John Brocksom; Sergio Pinheiro; Lucia Helena Brito Baptistella; Fernando Antonio Santos Coelho

• Advisor: Luiz Carlos Dias

Abstract

Epstein-Barr virus (EBV) is a human herpes virus that infects lymphocytes and epithelial cells. Is has been estimated that this virus infects a large part of the world¿s population. In 1995, stawamycin (1), a new natural product from the pyrroloketoindane family was isolated by Miao et. al from a liquid culture of Streptomyces sp, and displayed moderate inhibitory activity against the binding of the EBV BZLF1 transcription factor to DNA with IC50 = 50 mM in a DNA binding assay. Stawamycin has a trisubstituted trans-fused bicyclo[4.3.0]nonane substructure containing five stereogenic centres and a side chain that contains two stereogenic centres at C3 and C9 (absolute configuration not determined), a doubly allylic alcohol and a sodium carboxylate residue. To determine the relative configurations between C3 and C9, to establish the absolute configuration of stawamycin, and to provide material for further biological studies as well as access to novel analogues, we initiated a study towards the synthesis of this very interesting compound. We wish to describe here our successful efforts towards the preparation of the C1¿C6 as well as the C11¿C26 carbocyclic fragment of stawamycin. The bicyclo[4.3.0]nonane (C11¿C26) fragment of stawamycin has been prepared by a sequence involving 14 steps (7% overall yield) from methyl (R)-(-)-3-hydroxy-2- methylpropionate. Key steps are a Pd-catalysed Stille coupling reaction between a vinyl iodide and a vinyl stannane followed by an intramolecular Diels¿Alder cycloaddition reaction to give the desired adduct as the major isomer. The best result was obtained with the use of a triene bearing an achiral oxazolidinone in the presence of Et2AlCl to promote the IMDA cycloaddition reaction. The last step was an preparation of the tricyclic lactone followed by the opening by means of the 2-lítio-N-MEM-pirrol.The (C1¿C6) fragment of stawamycin has been prepared from diethyl-3- hydroxypentanedioate by a sequence which involved a symmetry breaking reaction of a cyclic anhydride, followed by the formation of a Z-vinyliodide employing a Stork-Wittig procedure. (AU)